SM200400022A - Composti farmaceutici transdermici - Google Patents

Composti farmaceutici transdermici

Info

Publication number
SM200400022A
SM200400022A SM200400022A SM200400022A SM200400022A SM 200400022 A SM200400022 A SM 200400022A SM 200400022 A SM200400022 A SM 200400022A SM 200400022 A SM200400022 A SM 200400022A SM 200400022 A SM200400022 A SM 200400022A
Authority
SM
San Marino
Prior art keywords
pharmaceutical compounds
transdermal pharmaceutical
transdermal
compounds
pharmaceutical
Prior art date
Application number
SM200400022A
Other languages
English (en)
Other versions
SM200400022B (it
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of SM200400022B publication Critical patent/SM200400022B/it
Publication of SM200400022A publication Critical patent/SM200400022A/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM200400022A 2003-10-23 2004-10-22 Composti farmaceutici transdermici SM200400022A (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1122MU2003 2003-10-23

Publications (2)

Publication Number Publication Date
SM200400022B SM200400022B (it) 2005-08-24
SM200400022A true SM200400022A (it) 2005-08-24

Family

ID=34531861

Family Applications (1)

Application Number Title Priority Date Filing Date
SM200400022A SM200400022A (it) 2003-10-23 2004-10-22 Composti farmaceutici transdermici

Country Status (24)

Country Link
US (1) US20070219171A1 (it)
EP (1) EP1686969A1 (it)
JP (1) JP2007509122A (it)
KR (1) KR20070000397A (it)
CN (1) CN100431531C (it)
AP (1) AP2006003628A0 (it)
AR (1) AR046146A1 (it)
AU (1) AU2004285335B2 (it)
BR (1) BRPI0415725A (it)
CA (1) CA2543245A1 (it)
HK (1) HK1098351A1 (it)
IL (1) IL175094A0 (it)
MA (1) MA28167A1 (it)
MX (1) MXPA06004460A (it)
NO (1) NO20062234L (it)
NZ (1) NZ547376A (it)
PA (1) PA8615501A1 (it)
PE (1) PE20050443A1 (it)
RU (1) RU2006117527A (it)
SM (1) SM200400022A (it)
SV (1) SV2006001916A (it)
TW (1) TW200524635A (it)
WO (1) WO2005041943A1 (it)
ZA (1) ZA200604036B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
CN102018671B (zh) * 2011-01-05 2012-07-25 浙江大学 一种雌二醇透皮喷雾剂及其制备方法
US20150065449A1 (en) * 2011-08-12 2015-03-05 Florida State University Research Foundation, Inc. Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG
GB201200062D0 (en) * 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
TWI516281B (zh) * 2014-07-16 2016-01-11 健維生技有限公司 改良之睪固酮製劑製法及所得之睪固酮製劑
US20170296484A1 (en) * 2015-11-23 2017-10-19 Grace Therapeutics Llc Topical Film-Forming Spray
WO2019140087A1 (en) * 2018-01-10 2019-07-18 Celista Pharmaceuticals Llc Testosterone transdermal spray with film
WO2020010205A1 (en) * 2018-07-05 2020-01-09 Celista Pharmaceuticals Llc Testosterone and estradiol transdermal spray
CN112206222A (zh) * 2018-11-09 2021-01-12 北京德默高科医药技术有限公司 含有布洛芬结构类似物的多层经皮给药系统
CN115154661A (zh) * 2022-07-29 2022-10-11 广州莱度品牌管理有限公司 一种仿生角质膜的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3868248D1 (de) * 1987-05-27 1992-03-12 Burghart Kurt Transdermal therapeutisch wirkende pharmazeutische zubereitung sowie vorrichtung zum aufbringen der zubereitung.
FR2732223B1 (fr) * 1995-03-30 1997-06-13 Sanofi Sa Composition pharmaceutique pour administration transdermique
FR2739031B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
IT1299566B1 (it) * 1998-07-17 2000-03-16 Ifi Istituto Farmacoterapico I Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina
JP2002536319A (ja) * 1999-02-05 2002-10-29 シプラ・リミテッド 局所用スプレー
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
US6274167B1 (en) * 2000-09-14 2001-08-14 Vincent Margiotta Topical anesthetic patch
US6528040B1 (en) * 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion

Also Published As

Publication number Publication date
ZA200604036B (en) 2007-09-26
JP2007509122A (ja) 2007-04-12
RU2006117527A (ru) 2007-12-10
AP2006003628A0 (en) 2006-06-30
CA2543245A1 (en) 2005-05-12
MXPA06004460A (es) 2006-06-27
SM200400022B (it) 2005-08-24
SV2006001916A (es) 2006-03-16
AU2004285335B2 (en) 2011-02-10
PE20050443A1 (es) 2005-06-14
PA8615501A1 (es) 2005-10-25
WO2005041943A1 (en) 2005-05-12
AR046146A1 (es) 2005-11-23
AU2004285335A1 (en) 2005-05-12
EP1686969A1 (en) 2006-08-09
NO20062234L (no) 2006-06-30
US20070219171A1 (en) 2007-09-20
CN100431531C (zh) 2008-11-12
BRPI0415725A (pt) 2006-12-19
IL175094A0 (en) 2006-08-20
NZ547376A (en) 2009-07-31
MA28167A1 (fr) 2006-09-01
TW200524635A (en) 2005-08-01
KR20070000397A (ko) 2007-01-02
CN1897927A (zh) 2007-01-17
HK1098351A1 (en) 2007-07-20

Similar Documents

Publication Publication Date Title
NO20054682D0 (no) Sikker transdermal doseringsform
DK2609947T3 (da) Plasterlignende infusionsapparat
DE602004017700D1 (de) Transmukosen verabreichung
DK1605897T3 (da) Polyethelen-glycol-link-glp-1-forbindelser
HUP0303313D0 (en) Transdermal pharmaceutical compositions
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
ATE333271T1 (de) Uv-stabiles transdermales pflaster
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK1587478T3 (da) Farmaceutisk sammensætning
NO20055143D0 (no) Doseringsformer innbefattende AG013736
FI20041129A0 (fi) Tioksotiatsolidinoniyhdisteitä lääkkeinä käytettäviksi
ATE354365T1 (de) N-thiazol-2-yl-benzamid-derivate
DK1597171T3 (da) Terapeutisk mikroskum
SM200400022A (it) Composti farmaceutici transdermici
IS8089A (is) Efnasambönd
NO20034952D0 (no) Farmasöytiske forbindelser
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
NO20031736D0 (no) Forbindelser
DE112004001429D2 (de) Pharmazeutischer Wirkstoff
ITMI20021041A0 (it) Composti farmaceutici che rilasciano no
DOP2003000794A (es) Nuevos compuestos farmaceuticos
ATE374639T1 (de) Elektrotherapievorrichtung
FI20030224A0 (fi) Uudet farmaseuttiset käytöt
SE0402678D0 (sv) Pharmaceutical use